Left Ventricular Noncompaction
Last Posted: Sep 30, 2021
- Reduced Systolic Function and Not Genetic Variants Determine Outcome in Pediatric and Adult Left Ventricular Noncompaction Cardiomyopathy.
Schultze-Berndt Alina et al. Frontiers in pediatrics 2021 9722926
- [Clinical pathway for cardiomyopathies: a genetic testing strategy proposed by ANMCO in Tuscany].
Girolami Francesca et al. Giornale italiano di cardiologia (2006) 2020 Dec 21(12) 926-934
- Screening for Fabry disease in patients with left ventricular noncompaction.
Azevedo Olga et al. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 2020 Jan
- Left ventricular noncompaction - Risk stratification and genetic consideration.
Ichida Fukiko et al. Journal of cardiology 2019 Oct
- 2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy.
Towbin Jeffrey A et al. Heart rhythm 2019 May
- Prevalence of pathogenic and likely pathogenic variants in the RASopathy genes in patients who have had panel testing for cardiomyopathy.
Aljeaid Deema et al. American journal of medical genetics. Part A 2019 Feb
- Genotype-Positive Status Is Associated With Poor Prognoses in Patients With Left Ventricular Noncompaction Cardiomyopathy.
Li Shijie et al. Journal of the American Heart Association 2018 Oct 7(20) e009910
- CLINGEN Actionability Report for Myofibrillar Myopathy -DES, BAG3, FLNC
ClinGen Actionability Working Group
- Genetic Testing in Pediatric Left Ventricular Noncompaction.
Miller Erin M et al. Circulation. Cardiovascular genetics 2017 Dec 10(6)
- Left ventricular noncompaction
From NCATS Genetic and Rare Diseases Information Center
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.